Ritedose Pharmaceuticals, LLC is a wholly owned subsidiary of The Ritedose Corporation, located in Columbia, SC. Ritedose launched into the generic inhalation space in February 2012 with an exceptional quality record and supply history. Products currently offered in the Inhalation Portfolio include: Albuterol Sulfate, Ipratropium Bromide, Iptratropium Bromide and Albuterol Sulfate combination product, Levalbuterol and Sodium Chloride for inhalation.Since 2012 Ritedose has delivered more than 1.7 Billion doses of nebulized inhalation medications without a field alert or recall. Trust in Ritedose Pharmaceuticals for your consistent supply of quality inhalation medications. We don't serve faceless patients, we serve you!